A TRAIL Receptor-Dependent Synthetic Lethal Relationship between MYC Activation and GSK3β/FBW7 Loss of Function

The MYC protooncogene is frequently deregulated in human cancers. Here, by screening a kinase-directed library of small inhibitory RNAs, we identify glycogen synthase kinase 3β (GSK3β) as a gene whose inactivation potentiates TNF-related apoptosis-inducing ligand death receptor-mediated apoptosis sp...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 102; no. 42; pp. 15195 - 15200
Main Authors Sabine Rottmann, Wang, Yan, Nasoff, Marc, Deveraux, Quinn L., Quon, Kim C.
Format Journal Article
LanguageEnglish
Published National Academy of Sciences 18.10.2005
National Acad Sciences
SeriesFrom the Cover
Subjects
Agonists
Apoptosis
Biological Sciences
Cell lines
Epithelial cells
Genetic screening
HCT116 cells
Phosphorylation
Receptors
Small interfering RNA
Tumors
Online AccessGet full text

Cover

More Information
Summary:The MYC protooncogene is frequently deregulated in human cancers. Here, by screening a kinase-directed library of small inhibitory RNAs, we identify glycogen synthase kinase 3β (GSK3β) as a gene whose inactivation potentiates TNF-related apoptosis-inducing ligand death receptor-mediated apoptosis specifically in MYC-overexpressing cells. Small inhibitory RNA-induced silencing of GSK3β prevents phosphorylation of MYC on T58, thereby inhibiting recognition of MYC by the E3 ubiquitin ligase component FBW7. Attenuating the GSK3β-FBW7 axis results in stabilization of MYC, up-regulation of surface levels of the TNF-related apoptosis-inducing ligand death receptor 5, and potentiation of death receptor 5-induced apoptosis in vitro and in vivo. These results identify GSK3β and FBW7 as potential cancer therapeutic targets and MYC as a critical substrate in the GSK3β survival-signaling pathway. The results also demonstrate paradoxically that MYC-expressing tumors might be treatable by drug combinations that increase rather than decrease MYC oncoprotein function.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Abbreviations: siRNA, small inhibitory RNA; siGL3, siRNA directed against luciferase; DR5, death receptor 5; TRAIL, TNF-related apoptosis-inducing ligand.
Author contributions: S.R., Q.L.D., and K.C.Q. designed research; S.R. and Y.W. performed research; M.N. contributed new reagents/analytic tools; S.R., Q.L.D., and K.C.Q. analyzed data; and Q.L.D. and K.C.Q. wrote the paper.
To whom correspondence should be addressed. E-mail: deveraux@gnf.org.
Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA
This paper was submitted directly (Track II) to the PNAS office.
Present address: Amgen San Francisco, 1120 Veterans Boulevard, South San Francisco, CA 94080.
K.C.Q. and Q.L.D. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0505114102